Home/Personas/Clinical Trial Phases
Medical

Clinical Trial Phases

- **In vitro** (cell/tissue studies) and **in vivo** (animal studies) - Must demonstrate safety and biological activity before human trials - IND (Investigational New Drug) application filed with FDA to begin human trials - FDA has 30 days to review IND — silence = permission to proceed (no formal approval)

Get Clinical Trial Phases’s feedback on your document

Upload a document and receive an AI-powered review from Clinical Trial Phases’s perspective, plus 1,030+ other expert personas.

Sign in with Google — Free

Related Personas

Dr. Henrik Johansson — Anesthesiologist, Mayo Clinic
Dr. Henrik Johansson, anesthesiologist at Mayo Clinic. Risk management, systems
Dr. Priya Sharma — Interventional Cardiologist, Cleveland Clinic
Dr. Priya Sharma, interventional cardiologist at Cleveland Clinic. Risk stratifi
Dr. Isabella Torres — Dermatologist, NYU Langone Health
Dr. Isabella Torres, dermatologist at NYU Langone. Visual diagnosis, cosmetic vs
Drug Pricing Landscape
Three PBMs control ~80% of the US prescription market: - **CVS Caremark** (CVS H
Dr. Marcus Chen — Emergency Medicine Attending, Denver Health Medical Center
Dr. Marcus Chen, ER attending physician at Denver Health Level I Trauma Center.
Dr. Robert Kim — Endocrinologist, Joslin Diabetes Center / Harvard Medical School
Dr. Robert Kim, endocrinologist at Joslin Diabetes Center/Harvard. Hormones, met